Weijun Wan

883 total citations · 1 hit paper
13 papers, 571 citations indexed

About

Weijun Wan is a scholar working on Molecular Biology, Cancer Research and Oncology. According to data from OpenAlex, Weijun Wan has authored 13 papers receiving a total of 571 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 7 papers in Cancer Research and 3 papers in Oncology. Recurrent topics in Weijun Wan's work include RNA modifications and cancer (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Cancer-related molecular mechanisms research (3 papers). Weijun Wan is often cited by papers focused on RNA modifications and cancer (6 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers) and Cancer-related molecular mechanisms research (3 papers). Weijun Wan collaborates with scholars based in China and Hong Kong. Weijun Wan's co-authors include Yongying Hou, Xiufeng Ye, Xia Pu, Ke Wang, Luoquan Ao, Quan Chen, Xiang Xu, Wei Xing, Yu Yang and Mengwei Yao and has published in prestigious journals such as Frontiers in Immunology, Molecular Cancer and Cell Death and Disease.

In The Last Decade

Weijun Wan

11 papers receiving 565 citations

Hit Papers

METTL3/IGF2BP3 axis inhibits tumor immune surveillance by... 2022 2026 2023 2024 2022 50 100 150 200 250
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer
    2022 276 citations Weijun Wan, Xiang Ao et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weijun Wan China 5 397 224 81 73 49 13 571
Lifeng Ding China 15 466 1.2× 287 1.3× 29 0.4× 65 0.9× 38 0.8× 38 699
Yi Luan China 15 334 0.8× 78 0.3× 22 0.3× 36 0.5× 96 2.0× 27 545
Lingling Yao China 8 312 0.8× 131 0.6× 38 0.5× 47 0.6× 54 1.1× 20 530
Xiao‐Jian Han China 17 538 1.4× 186 0.8× 28 0.3× 38 0.5× 84 1.7× 44 764
Meiling Zuo China 12 284 0.7× 151 0.7× 78 1.0× 19 0.3× 63 1.3× 16 483
Zhimei Hu China 13 634 1.6× 567 2.5× 49 0.6× 31 0.4× 189 3.9× 15 1.0k
Shun Xu China 11 297 0.7× 173 0.8× 38 0.5× 48 0.7× 26 0.5× 25 474
Yundong Zhang China 10 282 0.7× 88 0.4× 58 0.7× 33 0.5× 65 1.3× 18 422
Fengmeng Teng China 13 235 0.6× 175 0.8× 75 0.9× 32 0.4× 39 0.8× 24 467

Countries citing papers authored by Weijun Wan

Since Specialization
Citations

This map shows the geographic impact of Weijun Wan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weijun Wan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weijun Wan more than expected).

Fields of papers citing papers by Weijun Wan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weijun Wan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weijun Wan. The network helps show where Weijun Wan may publish in the future.

Co-authorship network of co-authors of Weijun Wan

This figure shows the co-authorship network connecting the top 25 collaborators of Weijun Wan. A scholar is included among the top collaborators of Weijun Wan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weijun Wan. Weijun Wan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Liu, Lu, Weijun Wan, Yilin Chang, et al.. (2025). Crosstalk between heterogeneous cancer-associated fibroblast subpopulations and the immune system in breast cancer: key players and promising therapeutic targets. Journal of Experimental & Clinical Cancer Research. 44(1). 263–263. 2 indexed citations
2.
3.
4.
Wan, Weijun, et al.. (2024). Incomplete Thermal Ablation-Induced FOXP4-Mediated Promotion of Malignant Progression in Liver Cancer via NDST2. Journal of Hepatocellular Carcinoma. Volume 11. 1945–1959. 2 indexed citations
5.
Wan, Weijun, et al.. (2024). RAD21: A Key Transcriptional Regulator in the Development of Residual Liver Cancer. Journal of Hepatocellular Carcinoma. Volume 11. 285–304. 1 indexed citations
6.
Chen, Quan, Weijun Wan, Juan Li, et al.. (2024). Decoding the prognostic landscape of LUAD: the interplay between N6-methyladenosine modification and immune microenvironment. Frontiers in Immunology. 15. 1514497–1514497.
7.
Ao, Luoquan, Wei Xing, Li Zhan, et al.. (2024). WTAP/YTHDF1-mediated m6A modification amplifies IFN-γ-induced immunosuppressive properties of human MSCs. Journal of Advanced Research. 71. 441–455. 11 indexed citations
8.
Wan, Weijun, Yuji Chen, Peng Lin, et al.. (2024). Exploring the impact of insufficient thermal ablation on hepatocellular carcinoma: NDST2 overexpression mechanism and its role in facilitating growth and invasion of residual cancer cells. International Journal of Hyperthermia. 41(1). 2353309–2353309. 1 indexed citations
9.
10.
Cheng, Yue, Shijie Li, Yongying Hou, et al.. (2023). Glioma-derived small extracellular vesicles induce pericyte-phenotype transition of glioma stem cells under hypoxic conditions. Cellular Signalling. 109. 110754–110754. 9 indexed citations
11.
Wan, Weijun, Xiang Ao, Quan Chen, et al.. (2022). METTL3/IGF2BP3 axis inhibits tumor immune surveillance by upregulating N6-methyladenosine modification of PD-L1 mRNA in breast cancer. Molecular Cancer. 21(1). 60–60. 276 indexed citations breakdown →
12.
Wan, Weijun, Yongying Hou, Ke Wang, et al.. (2019). The LXR-623-induced long non-coding RNA LINC01125 suppresses the proliferation of breast cancer cells via PTEN/AKT/p53 signaling pathway. Cell Death and Disease. 10(3). 248–248. 38 indexed citations
13.
Hou, Yongying, et al.. (2018). Resveratrol provides neuroprotection by regulating the JAK2/STAT3/PI3K/AKT/mTOR pathway after stroke in rats. Genes & Diseases. 5(3). 245–255. 229 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Lifeng Ding Breakdown of academic impact, for papers by Yi Luan Breakdown of academic impact, for papers by Lingling Yao Breakdown of academic impact, for papers by Xiao‐Jian Han Breakdown of academic impact, for papers by Meiling Zuo Breakdown of academic impact, for papers by Zhimei Hu Breakdown of academic impact, for papers by Shun Xu Breakdown of academic impact, for papers by Yundong Zhang Breakdown of academic impact, for papers by Fengmeng Teng
Rankless by CCL
2026